secwatch.observer — SEC 8-K summary
======================================

Issuer:     Organogenesis Holdings Inc. (ORGO)
CIK:        0001661181
Form:       8-K
Filed at:   2024-12-02T23:59:59+00:00
Accession:  0000950170-24-132248
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organogenesis repurchases 500K shares from director trust at $4.057/sh for $2M total
--------------------------------------------------------------------------------

- Repurchase of 500,000 shares from GN 2016 Family Trust (related to director Glenn Nussdorf) at $4.057/share, total $2.03M.
- Price based on 10-day trailing VWAP of common stock as of Nov 26, 2024.
- Repurchase approved by Audit Committee and a Transaction Committee of the Board due to related-party nature.
- Funded by proceeds from Nov 12, 2024 sale of Series A Convertible Preferred Stock to Avista Healthcare Partners.
- Closing expected on or around December 3, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661181/000095017024132248/0000950170-24-132248-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661181/000095017024132248/orgo-20241127.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-132248

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer